Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group
MOOSMANN, Nicolas, FISCHER VON WEIKERSTHAL, Ludwig, SCHULZE, Mathias, ABENHARDT, Wolfgang, PUCHTLER, Gerhard, KAPPAUF, Herbert, MITTERMÜLLER, Johann, HABERL, Christopher, SCHALHORN, Andreas, JUNG, Andreas, STINTZING, Sebastian, HEINEMANN, Volker, VEHLING-KAISER, Ursula, STAUCH, Martina, HASS, Holger G, DIETZFELBINGER, Herrmann, ORUZIO, Daniel, KLEIN, Stefan, ZELLMANN, Klaus, DECKER, Thomas
Published in Journal of clinical oncology (10.03.2011)
Published in Journal of clinical oncology (10.03.2011)
Get full text
Journal Article
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the AIO KRK 0104 trial
Modest, Dominik Paul, Laubender, Ruediger Paul, Fischer von Weikersthal, Ludwig, Vehling-Kaiser, Ursula, Stauch, Martina, Hass, Holger, Dietzfelbinger, Hermann F., Oruzio, Daniel V., Klein, Stefan, Zellmann, Klaus, Decker, Thomas, Schulze, Mathias, Abenhardt, Wolfgang, Puchtler, Gerhard, Kappauf, Herbert W., Mittermueller, Johann, Haberl, Christopher, Stintzing, Sebastian, Mansmann, Ulrich Robert, Heinemann, Volker
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article